These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24397753)

  • 1. Antidote shortages in the United States: impact and response.
    Hoffman RS
    Clin Toxicol (Phila); 2014 Mar; 52(3):157-9. PubMed ID: 24397753
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidote shortages in the USA: impact and response.
    ;
    J Med Toxicol; 2015 Mar; 11(1):144-6. PubMed ID: 25711999
    [No Abstract]   [Full Text] [Related]  

  • 3. Will There Ever be an Antidote for Drug Shortages?
    Fox ER; Johnson-Arbor K; Mazer-Amirshahi M
    J Med Toxicol; 2021 Jul; 17(3):321-322. PubMed ID: 33687652
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antidote availability in Norway].
    Solheim L; Andrew E; Jacobsen D
    Tidsskr Nor Laegeforen; 2002 Apr; 122(11):1111-3. PubMed ID: 12043055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New criteria proposed for poison antidote approvals, uses.
    Gloyd JS
    J Am Vet Med Assoc; 1992 Jul; 201(1):25-6. PubMed ID: 1644642
    [No Abstract]   [Full Text] [Related]  

  • 6. [Availability of antidotes in hospital pharmacies in the Czech Republic].
    Hrubý K
    Ceska Slov Farm; 2003 Sep; 52(5):231-40. PubMed ID: 14619700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Do you know where your cyanide kit is?': a study of perceived and actual antidote availability to emergency departments in the South West of England.
    Mitchell LJ; Higginson I; Smith JE; Swains L; Farrant J; Gagg J; Lindenbaum C; Mathieu N
    Emerg Med J; 2013 Jan; 30(1):43-8. PubMed ID: 22389349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update of antidote availability in veterinary medicine.
    Post LO; Keller WC
    Vet Hum Toxicol; 1999 Aug; 41(4):258-61. PubMed ID: 10434385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluate the impact of hospital types on the availability of antidotes for the management of acute toxic exposures and poisonings in Malaysia.
    Al-Sohaim SI; Awang R; Zyoud SH; Rashid SM; Hashim S
    Hum Exp Toxicol; 2012 Mar; 31(3):274-81. PubMed ID: 21478291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability of antidotes for the treatment of acute poisoning in Queensland public hospitals.
    Nissen LM; Wong KH; Jones A; Roberts DM
    Aust J Rural Health; 2010 Apr; 18(2):78-84. PubMed ID: 20398048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability of antidotes at acute care hospitals in Ontario.
    Juurlink DN; McGuigan MA; Paton TW; Redelmeier DA
    CMAJ; 2001 Jul; 165(1):27-30. PubMed ID: 11468950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonavailability of poison antidotes.
    Howland MA; Weisman R; Sauter D; Goldfrank L
    N Engl J Med; 1986 Apr; 314(14):927-8. PubMed ID: 2936959
    [No Abstract]   [Full Text] [Related]  

  • 13. Antidote availability in Quebec hospital pharmacies: impact of N-acetylcysteine and naloxone consumption.
    Bailey B; Bussières JF
    Can J Clin Pharmacol; 2000; 7(4):198-204. PubMed ID: 11118966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability of antidotes in hospital pharmacies in Greece.
    Plataki M; Anatoliotakis N; Tzanakis N; Assithianakis P; Tsatsakis AM; Bouros D
    Vet Hum Toxicol; 2001 Apr; 43(2):103-5. PubMed ID: 11308116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antidotes availability in Emergency Departments of the Italian National Health System and development of a national data-bank on antidotes].
    Locatelli C; Petrolini V; Lonati D; Butera R; Bove A; Mela L; Manzo L
    Ann Ist Super Sanita; 2006; 42(3):298-309. PubMed ID: 17124354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compounding for treatment of toxicosis.
    Bagley CV
    J Am Vet Med Assoc; 1994 Jul; 205(2):214-7. PubMed ID: 7928580
    [No Abstract]   [Full Text] [Related]  

  • 17. The cost of maintaining adequate antidote supplies.
    Bailey B; Bussières JF
    CMAJ; 2001 Nov; 165(11):1467. PubMed ID: 11762566
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and institutional aspects of antidote therapy in Russia.
    Ostapenko YN; Luzhnikov EA; Nechiporenko SP; Petrov AN
    Przegl Lek; 2001; 58(4):290-2. PubMed ID: 11450355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atropine availability as an antidote for nerve agent casualties: validated rapid reformulation of high-concentration atropine from bulk powder.
    Geller RJ; Lopez GP; Cutler S; Lin D; Bachman GF; Gorman SE
    Ann Emerg Med; 2003 Apr; 41(4):453-6. PubMed ID: 12658242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Need for antidote for aluminium phosphide poisoning.
    Yadav J
    Indian J Physiol Pharmacol; 1997 Apr; 41(2):189. PubMed ID: 9142571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.